Online Inquiry
Cat.#: ACPP-1331
| Despition | GPR56 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1675 | Human TOR1A Protein (AC1675) | 5 µg | inquiry |
| ACPP-1118 | Human Insulin (Active) (AC1118) | 25 mg | inquiry |
| ACPP-1468 | Human MEIS3 Protein (AC1468) | 5 µg | inquiry |
| ACPP-1114 | Recombinant Human NCAM1 Protein (6×His Tag) (AC1114) | 50 µg | inquiry |
| ACPP-1407 | Human HOMER3 Protein (AC1407) | 5 µg | inquiry |
| ACPP-1084 | Recombinant Human Autotaxin Protein (Functional) (AC1084) | 10 µg | inquiry |
| ACPP-1705 | Human NXPH1 Protein (AC1705) | 5 µg | inquiry |
| ACPP-1217 | P2Y2 Blocking Peptide (AC1217) | 250 µg | inquiry |
| ACPP-1106 | Recombinant Human c-Kit Protein (6×His Tag) (AC1106) | 50 µg | inquiry |
| ACPP-1301 | SHISA9 Blocking Peptide (AC1301) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.